Skip to content

Prosthetic Performance Enhancement Trial

Prosthetic Performance Enhancement Trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06419920
Acronym
PROSPER
Enrollment
35
Registered
2024-05-17
Start date
2025-06-26
Completion date
2027-07-01
Last updated
2026-06-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Amputation, Lower Limb Amputation Above Knee (Injury), Lower Limb Amputation at Ankle (Injury), Lower Limb Amputation at Hip (Injury), Lower Limb Amputation Below Knee (Injury), Lower Limb Amputation Knee

Brief summary

The purpose of this research is to determine the feasibility of an uneven terrain walking program for lower limb prosthesis users. The training is designed to induce step-to-step variability during walking within a safe environment, with the aim of improving walking skill and confidence.

Detailed description

Despite advances in the technology for artificial limbs (prostheses), falling and the fear of falling continue to be barriers to mobility for many lower limb prosthesis users after their initial rehabilitation. The loss of ability and confidence in pursuing everyday tasks negatively impacts quality of life, and ongoing physical and mental health. This study will test and improve a rehabilitation training intervention involving walking on uneven ground to improve walking skill and confidence in lower limb prosthesis users. Lower limb prosthesis users will be recruited. Participants will be allocated randomly to receive either intervention A: training on a flat surface, or intervention B: training on an uneven surface. Depending on their ability and confidence, participants will complete the walking practice either on a treadmill or on a mat with an identical surface pattern. The walking practice will take place three times per week for four weeks. As each participant improves their ability, training tasks will be made more difficult by limiting handrail use, by increasing walking speed, and, for intervention B, also by making the walking surface more uneven. The objectives of this pilot study are to evaluate adherence and refine the training protocols in preparation for a definitive trial that will inform rehabilitation practices.

Interventions

OTHERFlat terrain locomotor training

The training will be comprised of up to 12 sets of 2-min continuous walking on a level treadmill or mat, interspersed with rest breaks of at least one minute. Training will be completed three times per week for four weeks.

OTHERUneven terrain locomotor training

The training will be comprised of up to 12 sets of 2-min continuous walking on an uneven terrain treadmill or mat, interspersed with rest breaks of at least one minute. Training will be completed three times per week for four weeks.

Sponsors

University of Nevada, Las Vegas
Lead SponsorOTHER
University of Washington
CollaboratorOTHER
Chapman University
CollaboratorOTHER
United States Department of Defense
CollaboratorFED
National Institutes of Health (NIH)
CollaboratorNIH

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
SINGLE (Outcomes Assessor)

Intervention model description

Feasibility study incorporating a single-blinded Phase I clinical trial with a parallel groups design, involving two treatment conditions: uneven terrain training (UT) and flat terrain (FT) training. Participants will be allocated randomly to UT and FT arms in a 6:1 ratio.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* lower limb amputation at ankle (Symes) level and above * age 18+ years * fitted with a walking prosthesis and use it regularly for home and/or community ambulation * good socket fit, assessed by a score of 8-10 on the socket fit comfort scale * able to walk for three minutes at a time with or without an assistive device

Exclusion criteria

* leg/foot ulcer or other conditions that cause pain during weight-bearing * poor skin integrity that could cause tissue breakdown by walking * cardiovascular, respiratory or other critical health conditions that preclude moderate physical activity * unilateral or bilateral upper limb absence or loss at the wrist and above that precludes use of handrails bilaterally, or would require asymmetrical adaptation to body posture for use. * pregnancy

Design outcomes

Primary

MeasureTime frameDescription
Session adherenceThrough study completion, over 4 weeksPercentage of planned sessions attended, per participant.

Secondary

MeasureTime frameDescription
L-test timePre-intervention, within 5 days post interventionTime to complete L-test, in s. Participant rises from a chair and guided by cones, walks 10m forward, turns 90 degrees, walks a further 10m, turns 180 degrees, then follows the same path back to the chair and sits. Result from a single test following one practice trial is recorded.
Activities-specific Balance Confidence Scale summary scorePre-intervention, within 5 days post intervention16-item self report measure recording confidence in performing activities during daily life that require balance, on numerical ratings scale, recorded as a percentage (out of 100).
Average daily activityPre-intervention, within 5 days post interventionMean number of steps per day over 7 days, collected using ankle worn activity monitor.
Four Square Step Test timePre-intervention, within 5 days post interventionTime to complete forwards, lateral and backwards stepping pattern, in s.
Single leg stand timePre-intervention, within 5 days post interventionTime standing on one leg up to a maximum of 20s, in s.
Two-minute walk test distancePre-intervention, within 5 days post interventionWalking distance traveled in two minutes, in m.
Protocol acceptabilityEnd of intervention week 4Likert scale questions and short answer questions to determine acceptability of protocol to participants, assessed qualitatively.
Recruitment feasibility - recruitment rateFrom start of recruitment period, to 12 month time point.Number of participants recruited within one year
Recruitment feasibility - participating clinicsThrough study completion, from start of recruitment period, to end of recruitment period or 30 month time point, whichever is sooner.Number of clinics from which at least one participant is recruited.
Recruitment feasibility - sample characteristicsThrough study completion, from start of recruitment period, to end of recruitment period or 30 month time point, whichever is sooner.Sample characteristics of all participants enrolled in the study, regardless of completion.
Activity data evaluationThroughout activity monitoring period, over 2 weeksCompleteness and quality of activity monitor data, measured as number of days with valid (non-erroneous) monitoring data.
Maximum relative variability of lateral trunk velocity during uneven terrain in comparison to overground walkingThrough study completion, over 4 weeksMedial-lateral trunk variability will be quantified during each bout of walking during each session. The maximum relative variability will be calculated as the difference in variability (standard deviation) of peak per-step lateral trunk velocity during UT walking sessions relative to that of overground walking, in m/s.
Contour depth at maximum relative variabilityThrough study completion, over 4 weeksTerrain contour depth at which the maximum relative variability was recorded, in m.
Maximum relative step width variability during uneven terrain in comparison to overground walkingThrough study completion, over 4 weeksStep width variability will be quantified during each bout of walking during each session. The maximum relative variability will be calculated as the difference in variability (standard deviation) of step width during UT walking sessions relative to that of overground walking, in m.
Prosthesis Users Survey of Mobility t-scorePre-intervention, within 5 days post intervention12-item self report tool measuring prosthesis users' mobility.

Countries

United States

Contacts

CONTACTJenny A Kent, PhD, CSci
jenny.kent@unlv.edu7028955949
PRINCIPAL_INVESTIGATORJenny A Kent, PhD, CSci

University of Nevada, Las Vegas

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 24, 2026